Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Savolitinib + Cetuximab + FOLFOX in mCRC
NCT07683403Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of savolitinib in colorectal cancer (CRC), sponsored by Fudan University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
savolitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07683403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683403.